Hogan Lovells Cadwalader

Corporate transactions and mandates on which Hogan Lovells Cadwalader has been named counsel, verified against primary filings and tracked by CorpLawTracker.

Tracked mandates

• Molbio Diagnostics IPO: ₹939.7 cr book-built raise comprising ₹200 cr fresh issue & ₹739.7 cr OFS, listed Aug 17 at ₹980/share (21% premium).17 Aug 2026 · ₹939.696 cr · Pharma & Healthcare
• <b>APAR Industries completes ₹2,500 cr QIP at ₹14,805/share</b>, placing 16.88 lakh shares to institutional buyers.13 Aug 2026 · ₹2,500 cr · Industrials